Ovarian Cancer: Recent Innovations and Standards of Care
Optimal cytoreductive surgery and taxane/platinum chemotherapy remain the hallmarks of primary management of ovarian cancer. There are major advancements in the surgical and medical management and outcomes for ovarian cancer. Learn some of these ovarian cancer treatment innovations from Ginger J. Gardner, M.D., of Memorial Sloan Kettering Cancer Center.
General Surgeons, Reconstructive Surgeons, Obstetricians and Gynecologists, Oncologists, Medical Oncologists, Physiatrists, Radiation Oncologists, General Practitioners and all other interested healthcare professionals.
- Explain the major advances in ovarian cancer treatment and research.
- Apply evidence-based data to design treatment strategies for newly diagnosed patients.
Ginger J. Gardner, M.D.
Vice Chair, Department of Surgery for Hospital Operations
Surgical Chair, Institutional Patient Flow Committee
Lead Physician, Gynecology Disease Management Team Alliance
Ovarian Cancer Surgery Section, Gynecology Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, N.Y.
Ginger J. Gardner, M.D., faculty for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Gladys L. Giron, M.D., has indicated that her spouse is a member of the speakers' bureau and a consultant with Stryker.
John P. Diaz, M.D., has indicated that he is a member of the speakers' bureau with AstraZeneca and a consultant with ConMed and Intuitive Surgical.
All of the relevant financial relationships listed for these individuals have been mitigated.
Nicholas C. Lambrou, M.D., and Starr K. Mautner, M.D., have no relevant financial relationship with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.